July 14, 2026 |

Understanding the Tiny Bad Actors in the Brain

By H Conley

Over in America live with Alzheimer���s disease, the nation���s . Available treatments show even though scientists have researched the disease Questions persist about why and how it develops.

In 1984, scientists identified clumps of proteins in the brains of Alzheimer’s patients. They hypothesized these amyloid-帣 plaques might cause the disease. Researchers have developed drugs to hopefully prevent such build-ups but have not successfully reversed the course of the disease.

���That’s why researchers have been looking for other possible things to target,��� says , who recently received her doctorate from the CUNYGraduate Center. ���And that’s where microglia come in.���

While neurons are the most well-known cells in the brain, they share the brain with . Glia provide essential support including insulation, structural maintenance, and nutrient transport. Flury focused on microglia ��� the brain’s immune cells, which are the smallest glia. ���While they may be micro, their small size doesn���t indicate that they have a small stature in the brain,��� Flury says. ���They’re very important for maintaining homeostasis.���

Within one brain, there is a wide variety of microglia performing many functions. Some surveil their environment, sensing anything that shouldn’t be there ��� such as bacteria or a neighboring cell that’s dying. They eat and digest the interlocuters and remove them from the brain. Glia also shape the synaptic landscape of the brain. Neurons make trillions of physical connections with each other called synapses, and microglia can both remove or encourage them.

���Microglia can be protective, but they can also contribute to neuron death,��� says Flury. ���What our research was looking at was whether, in an Alzheimer’s patient, there is a subcategory of microglia that’s doing something harmful that promotes the disease.���

One major effect of Alzheimer’s, in addition to a broad loss of memory and neurons, is the loss of synapses between neurons. In people with Alzheimer���s, these bonds are removed by overactive microglia. ���They normally play a good role in removing connections that maybe you don���t need, because you don’t use very much,��� says Flury. ���In the disease, maybe that gets heightened, and they start to remove connections that they shouldn’t be removing.���

Flury hypothesized that these bad actor microglia might be responding to cellular stress ��� a problem such as a misfolded protein or viral infection. Since microglia are immune cells, they can release small molecules that signal cells around them. Flury wondered if these cells released something toxic to their neighbors.

Her team in ��first put microglia on a dish to capture and test what they released. Then, they applied that excretion onto neurons. ���We found that if the microglia were stressed, and we put that media onto neurons, the neurons would die,��� says Flury.

The team then determined that stressed microglia excreted lipids. They found that if they injected mice with something that inhibited lipid production, those mice lost fewer neuronal connections. This improvement at the neuron connection level might indicate an improvement at the level of memory.

This research serves as an important step in furthering our understanding of Alzheimer’s. However, much more will need to be determined before it can have clinical implications.

���We figured out in broad terms that it’s a lipid, but there’s so many different types of lipids out there and it might not be a good idea to just inhibit all lipid synthesis,��� says Flury. The human brain is so inhibiting lipid production could have major side effects.

This fact led to a to pinpoint the specific lipid to target within the microglia.

Further research into these microglial excretions could have positive impacts for people experiencing many neurodegenerative diseases, not just Alzheimer���s. ���There���s more and more evidence of microglial involvement and the activation of cellular stress pathways in Parkinson’s, Huntington’s and A.L.S.,��� says Flury. ���So, I hope to see that paradigm shift in my lifetime.���